ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
83,065
0,36%
Bitcoin
63 783,24
-0,17%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Morphic Holding Inc (MORF)

  7. Morphic Holding Inc (MORF) Actualités

MORF Morphic Holding Inc

29,90
1,19 (4,14%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Morphic Holding Inc MORF NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
1,19 4,14% 29,90 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
29,85 29,075 30,30 29,90 28,71
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202413:00GLOBEMorphic Announces Corporate Highlights and Financial Results..
19/3/202413:00GLOBEMorphic Appoints Dr. Simon Cooper as Chief Medical Officer
05/3/202422:05GLOBEMorphic to Participate in March Investor Conferences
22/2/202413:46EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202413:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202413:04EDGAR2Form 8-K - Current report
22/2/202413:00GLOBEMorphic Announces Corporate Highlights and Financial Results..
18/1/202401:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:08EDGAR2Form 8-K - Current report
03/1/202422:05GLOBEMorphic to Present at the 42nd Annual J.P. Morgan Healthcare..
06/12/202314:57EDGAR2Form 8-K - Current report
10/11/202314:00GLOBEMorphic to Present at November Investor Conferences
03/11/202312:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202312:13EDGAR2Form 8-K - Current report
03/11/202312:00GLOBEMorphic Announces Corporate Highlights and Financial Results..
12/10/202314:52EDGAR2Form 8-K - Current report
09/10/202314:00GLOBEMorphic Therapeutic to Host Webcast to Present EMERALD-1..
26/9/202323:30EDGAR2Form 8-K - Current report
26/9/202322:10GLOBEMorphic Holdings Announces CEO Dr. Praveen Tipirneni to Take..
22/9/202323:30GLOBEMorphic to Present Positive EMERALD-1 Phase 2a Data for..
09/9/202301:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202322:24EDGAR2Form 144 - Report of proposed sale of securities
29/8/202314:00GLOBEMorphic Announces Participation in 2023 Wells Fargo..
09/8/202322:05GLOBEMorphic to Present at the Canaccord Genuity 43rd Annual..
04/8/202300:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202313:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202313:08EDGAR2Form 8-K - Current report
03/8/202313:05GLOBEMorphic Announces Corporate Highlights and Financial Results..
07/7/202301:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202322:05GLOBEMorphic to Present at the Jefferies Global Healthcare..
12/5/202314:30GLOBEMorphic to Present at 2023 RBC Capital Markets Global..
11/5/202314:00GLOBEMorphic Presents New Biomarker Data at DDW 2023 Supporting..

Dernières Valeurs Consultées

NASDAQ
MORF
Morphic
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés